Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 1,304 | 1,533 | 1,002 | 325 | 351 |
| Operating Income | -1,304 | -1,533 | -1,002 | -325 | -351 |
| Other Income | 496 | 501 | 497 | 546 | 654 |
| Pre-tax Income | -808 | -1,032 | -505 | 221 | 303 |
| Income Tax | 16 | -42 | 19 | 293 | 49 |
| Net Income Continuous | -824 | -990 | -524 | -72 | 254 |
| Net Income | $-824 | $-990 | $-524 | $-72 | $254 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.01 | N/A | 0.00 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.01 | N/A | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.02 | -0.01 | 0.00 | 0.00 |
| EBITDA(a) | $-1,304 | $-1,533 | $-1,002 | $-325 | $-351 |